Evidence map›Paper›PMID 20498275›Full record

ArticleMolecular and cellular biology2010

Interplay between DNA methylation and transcription factor availability: implications for developmental activation of the mouse Myogenin gene.

Daniela Palacios, Dennis Summerbell, Peter W J Rigby, Joan Boyes

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Article
  3. AnAnimals : an open access journal from MDPI · 2022
    Article
  4. Article
  5. Review
  6. Article
  7. Mitochondrial Function in Muscle Stem Cell Fates.Frontiers in cell and developmental biology · 2020
    Review
  8. Article
  9. DNMT1 inJournal of the American Society of Nephrology : JASN · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Daniela PalaciosSection of Gene Function and Regulation, Institute of Cancer Research, London, United Kingdom.
Dennis Summerbell
Peter W J Rigby
Joan Boyes
Institute of Cancer Research · GBUniversity of Leeds · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During development, gene activation is stringently regulated to restrict expression only to the correct cell type and correct developmental stage. Here, we present mechanistic evidence that suggests DNA methylation contributes to this regulation by suppressing premature gene activation. Using the mouse Myogenin promoter as an example of the weak CpG island class of promoters, we find that it is initially methylated but becomes demethylated as development proceeds. Full hypersensitive site formation of the Myogenin promoter requires both the MEF2 and SIX binding sites, but binding to only one site can trigger the partial chromatin opening of the nonmethylated promoter. DNA methylation markedly decreases hypersensitive site formation that now occurs at a detectable level only when binding to both MEF2 and SIX binding sites is possible. This suggests that the probability of activating the methylated promoter is low until two of the factors are coexpressed within the same cell. Consistent with this, the single-cell analysis of developing somites shows that the coexpression of MEF2A and SIX1, which bind the MEF2 and SIX sites, correlates with the fraction of cells that demethylate the Myogenin promoter. Taken together, these studies imply that DNA methylation helps to prevent inappropriate gene activation until sufficient activating factors are coexpressed.

Indexed as

DNA MethylationAnimalsBinding SitesChromatinCpG IslandsEmbryo, MammalianGenesHomeodomain ProteinsMEF2 Transcription FactorsMethylationMiceMice, TransgenicMyogenic Regulatory FactorsMyogeninTranscriptional ActivationTranscription FactorsChromatinHomeodomain ProteinsMEF2 Transcription FactorsMyogenic Regulatory FactorsMyogeninSIX1 protein, humanTranscription Factors

Identifiers

PMID20498275
PMCPMC2916394
OpenAlexW2165567873

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.